EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 30 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,885 | -81.0% | 253,326 | -68.2% | 0.02% | -73.0% |
| Q1 2022 | $15,164 | -86.5% | 797,241 | -81.1% | 0.06% | -81.4% |
| Q4 2021 | $111,996 | -56.7% | 4,218,302 | -33.0% | 0.34% | -45.4% |
| Q3 2021 | $258,696 | -36.4% | 6,297,359 | -12.3% | 0.62% | -18.0% |
| Q2 2021 | $406,678 | +10.6% | 7,180,055 | -18.0% | 0.76% | +3.7% |
| Q1 2021 | $367,581 | -48.2% | 8,751,923 | -13.6% | 0.73% | -61.4% |
| Q4 2020 | $709,903 | +137.1% | 10,125,564 | -5.1% | 1.89% | +6.4% |
| Q3 2020 | $299,412 | +34.1% | 10,670,424 | +41.4% | 1.78% | -26.0% |
| Q2 2020 | $223,215 | +111.0% | 7,546,146 | +41.4% | 2.40% | -8.9% |
| Q1 2020 | $105,812 | -19.6% | 5,335,941 | +20.0% | 2.64% | -20.6% |
| Q4 2019 | $131,684 | +17.4% | 4,447,277 | -9.8% | 3.32% | +35.7% |
| Q3 2019 | $112,163 | -6.5% | 4,932,398 | +1.7% | 2.45% | -19.0% |
| Q2 2019 | $119,943 | +7.6% | 4,848,148 | +6.3% | 3.02% | -5.1% |
| Q1 2019 | $111,478 | +62.0% | 4,559,434 | +50.8% | 3.18% | +14.0% |
| Q4 2018 | $68,807 | -22.6% | 3,024,489 | +8.3% | 2.79% | +4.0% |
| Q3 2018 | $88,900 | +13.7% | 2,793,854 | +28.1% | 2.69% | -6.2% |
| Q2 2018 | $78,166 | +45.5% | 2,181,572 | +34.6% | 2.86% | +7.4% |
| Q1 2018 | $53,710 | +57.1% | 1,620,208 | +45.6% | 2.67% | -2.1% |
| Q4 2017 | $34,198 | +299.5% | 1,112,845 | +118.1% | 2.72% | +63.4% |
| Q2 2017 | $8,561 | +66.8% | 510,187 | +121.9% | 1.67% | +12.7% |
| Q1 2017 | $5,132 | – | 229,922 | – | 1.48% | – |
Download | ||||||